Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Director departure
ALPHARMA INC (ALO) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/17/2009 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2009 SC 13G THOMPSON SIEGEL & WALMSLEY LLC reports a 0% stake in ALPHARMA INC.
02/03/2009 SC 13G/A BARCLAYS GLOBAL INVESTORS NA reports a 0% stake in ALPHARMA INC
01/16/2009 15-12B Form 15-12B -- Securities registration termination [Section 12(b)]
01/15/2009 EFFECT Form EFFECT -- Effectiveness Date: 2009-01-14 Registration Form: POS AM Reference AccNo: 0000950123-09-000566
01/15/2009 EFFECT Form EFFECT -- Effectiveness Date: 2009-01-14 Registration Form: POS AM Reference AccNo: 0000950123-09-000568
01/15/2009 EFFECT Form EFFECT -- Effectiveness Date: 2009-01-14 Registration Form: POS AM Reference AccNo: 0000950123-09-000569
01/15/2009 EFFECT Form EFFECT -- Effectiveness Date: 2009-01-14 Registration Form: POS AM Reference AccNo: 0000950123-09-000567
01/15/2009 EFFECT Form EFFECT -- Effectiveness Date: 2009-01-14 Registration Form: POS AM Reference AccNo: 0000950123-09-000570
01/13/2009 S-8 POS Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments
01/13/2009 S-8 POS Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments
01/13/2009 S-8 POS Form S-8 POS -- Securities to be offered to employees in employee benefit plans, post-effective amendments
01/13/2009 POSASR Form POSASR -- Post-effective Amendment to an automatic shelf registration statement
01/13/2009 POS AM Form POS AM -- Post-Effective amendments for registration statement
01/13/2009 POS AM Form POS AM -- Post-Effective amendments for registration statement
01/13/2009 POS AM Form POS AM -- Post-Effective amendments for registration statement
01/13/2009 POS AM Form POS AM -- Post-Effective amendments for registration statement
01/13/2009 POS AM Form POS AM -- Post-Effective amendments for registration statement
01/08/2009 SC 13D KING PHARMACEUTICALS INC has filed a Schedule 13D for Alpharma Inc.
01/06/2009 8-K Quarterly results
01/06/2009 25-NSE Form 25-NSE --
01/05/2009 8-K Form 8-K -- Current report
01/02/2009 4 UPRICHARD DAVID C (Director) has filed a Form 4 on ALPHARMA INC
Txns: Disposed/sold 1,500 shares @ $0
Disposed/sold 10,201 restricted stock units @ $37, valued at $377.4k
12/31/2008 4 Form 4 - Statement of changes in beneficial ownership of securities
12/31/2008 4 Perez Ray (Director) has filed a Form 4 on ALPHARMA INC
12/31/2008 4 Watts Peter (EVP, HR and Communications) has filed a Form 4 on ALPHARMA INC
12/31/2008 4 PETER LADELL W (Director) has filed a Form 4 on ALPHARMA INC
12/31/2008 4 Jacobsen Finn Berg (Director) has filed a Form 4 on ALPHARMA INC
12/31/2008 4 Shively Richard Scott (See Remarks) has filed a Form 4 on ALPHARMA INC
12/31/2008 4 Spellman Thomas J III (Exec VP, Gen Counsel & Sec) has filed a Form 4 on ALPHARMA INC
12/31/2008 4 Buzinkai Donald (See Remarks) has filed a Form 4 on ALPHARMA INC
12/31/2008 4 MITCHELL DEAN J (President and CEO) has filed a Form 4 on ALPHARMA INC
12/31/2008 4 CAMPBELL JEFFREY (See Remarks) has filed a Form 4 on ALPHARMA INC
12/31/2008 4 TOMBROS PETER (Director) has filed a Form 4 on ALPHARMA INC
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy